Bayer, a global pharmaceutical and biotechnology company, is collaborating with Google Cloud to enhance its pharmaceutical business using AI. This partnership aims to streamline clinical trials and drug discovery processes by leveraging Google Cloud’s Tensor Processing Units (TPUs) for quantum chemistry calculations. It will also utilise Google Cloud’s Vertex AI and Med-PaLM 2 to analyse large datasets and generate insights for research and development. Additionally, Bayer plans to use AI to automate regulatory documentation, improving efficiency in the compliance process. The partnership also focuses on AI applications in radiology to enhance patient care. This collaboration reflects the growing potential of AI in healthcare and its ability to transform various aspects of pharmaceutical research and development.